Corrugated Asbestos Paper

Product Description

Corrugated asbestos paper was an industrial building and insulation material manufactured by G-I Holdings and used across a wide range of commercial and industrial applications from 1928 through 1981. The product was produced in corrugated sheet form, giving it structural rigidity while maintaining the lightweight and fire-resistant characteristics that made asbestos-containing materials highly sought after throughout much of the twentieth century.

The corrugated format served several practical purposes in industrial settings. The wave-like profile of the sheets increased their load-bearing capacity relative to flat paper products of the same thickness, making corrugated asbestos paper suitable for applications including roofing underlayment, pipe wrap, thermal insulation backing, and partition panels in high-temperature industrial environments. Facilities such as foundries, power plants, chemical processing plants, and manufacturing operations commonly incorporated the material into their construction and equipment insulation systems.

G-I Holdings, a successor entity connected to the former GAF Corporation and its predecessor companies, was among the producers of corrugated asbestos paper during the product’s active manufacturing period. The company’s involvement in asbestos-containing product manufacturing placed it at the center of significant asbestos litigation that developed from the 1970s onward as the health consequences of occupational asbestos exposure became more widely documented and legally actionable.

Production of corrugated asbestos paper continued through 1981, a period that overlapped with increasing regulatory scrutiny of asbestos-containing materials. The United States Environmental Protection Agency’s Asbestos Hazard Emergency Response Act (AHERA) and OSHA’s permissible exposure limit regulations, which were progressively tightened during the 1970s and 1980s, reflected growing scientific and governmental consensus that airborne asbestos fibers posed serious risks to human health.

Asbestos Content

Corrugated asbestos paper manufactured by G-I Holdings contained chrysotile asbestos, the most commonly used variety of asbestos in commercial and industrial products throughout the twentieth century. Chrysotile, sometimes referred to as white asbestos, belongs to the serpentine mineral group and was valued for its flexibility, tensile strength, and resistance to heat and chemical degradation.

In corrugated asbestos paper, chrysotile fibers were typically integrated into the paper matrix during the manufacturing process. The fibers were combined with paper pulp and binding agents, then formed into sheets and corrugated before curing. This bonding process was intended to fix the fibers within the product structure, but the integrity of that bond was not permanent. Mechanical disturbance, aging, weathering, and normal wear could cause the matrix to degrade over time, releasing fibers into the surrounding environment.

While chrysotile is sometimes characterized as less hazardous than amphibole asbestos varieties such as crocidolite or amosite, regulatory agencies and medical research have established that chrysotile exposure is associated with serious asbestos-related diseases, including mesothelioma, asbestosis, and lung cancer. OSHA’s current regulations do not distinguish between asbestos fiber types with respect to permissible exposure limits, treating all forms of asbestos as equally regulated hazardous substances in occupational settings.

How Workers Were Exposed

Industrial workers generally represent the primary population documented as having been exposed to corrugated asbestos paper during its manufacture, installation, and maintenance. Exposure pathways varied depending on the specific role a worker performed and the conditions of the worksite.

Workers involved in the installation of corrugated asbestos paper as roofing underlayment or pipe insulation wrap were at risk of exposure when cutting, trimming, or fitting sheets to specifications. These operations typically involved sawing, scoring, or breaking the material, each of which could generate airborne asbestos dust in concentrations that exceeded safe exposure thresholds, particularly in enclosed or poorly ventilated spaces.

Maintenance and renovation workers in industrial facilities where corrugated asbestos paper had been installed faced ongoing exposure risks when aging or damaged materials were disturbed. Deteriorated asbestos paper that had become friable — meaning it could be crumbled by hand pressure — was particularly prone to releasing respirable fibers during routine maintenance, equipment servicing, or repair work.

Workers in manufacturing environments who handled the raw product in bulk, whether in storage, transport, or as a component in larger assembly processes, were also subject to incidental fiber release from the product surface or edges. In industrial facilities lacking adequate engineering controls or respiratory protection, ambient fiber concentrations could accumulate over the course of a workday or work career.

The latency period associated with asbestos-related diseases — often ranging from ten to fifty years between initial exposure and clinical diagnosis — means that workers exposed to corrugated asbestos paper during its production years may still be developing related conditions today. Diseases such as malignant pleural mesothelioma, which has a strong and well-documented association with asbestos exposure, may not become apparent until decades after the occupational exposure occurred.

G-I Holdings does not maintain an active asbestos bankruptcy trust fund accessible to claimants exposed to corrugated asbestos paper. As a result, individuals who allege harm from exposure to this product have pursued compensation through direct civil litigation rather than through the trust fund system that governs claims against many other asbestos product manufacturers.

Litigation records document that G-I Holdings faced asbestos-related personal injury claims arising from its manufacturing activities, including claims connected to corrugated asbestos paper and other asbestos-containing products associated with its predecessor entities. Plaintiffs alleged that G-I Holdings and its corporate predecessors manufactured, distributed, and sold products containing asbestos while having access to information about the health hazards of asbestos exposure, and that adequate warnings were not provided to the workers who used or encountered these products.

Plaintiffs alleged in asbestos litigation involving G-I Holdings that corporate knowledge of asbestos-related health risks predated the public regulatory response to those risks by years or decades, and that this knowledge imposed a duty to warn that was not met. These allegations have formed the basis of negligence, strict liability, and failure-to-warn claims in jurisdictions across the United States.

Individuals who believe they have been harmed by exposure to corrugated asbestos paper or other asbestos-containing products associated with G-I Holdings should take the following steps:

  • Consult a qualified asbestos attorney experienced in toxic tort litigation. Many asbestos attorneys offer free case evaluations and work on a contingency basis.
  • Document your work history as thoroughly as possible, including employer names, job sites, dates of employment, and specific tasks performed involving asbestos-containing materials.
  • Obtain a confirmed medical diagnosis from a physician experienced in asbestos-related diseases. A documented diagnosis is foundational to any legal claim.
  • Act within applicable statutes of limitations. Deadlines for filing asbestos claims vary by state and by the date of diagnosis or discovery of harm. Delays can permanently bar recovery.

Because no trust fund exists for claims against G-I Holdings related to this product, legal options are pursued through the court system, and the outcome of individual cases depends on the specific facts, jurisdiction, and legal theories presented. An experienced asbestos litigation attorney can assess whether a civil claim is viable based on your documented exposure history and medical condition.